共 176 条
[1]
Trotti A(2007)Patient-reported outcomes and the evolution of adverse event reporting in oncology J Clin Oncol 25 5121-5127
[2]
Colevas AD(2009)Patient-reported outcomes in drug safety evaluation Ann Oncol 20 1905-1906
[3]
Setser A(2006)Patient versus clinician symptom reporting using the National Cancer Institute common terminology criteria for adverse events: results of a questionnaire-based study The Lancet Oncology 7 903-909
[4]
Basch E(2015)Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials J Clin Oncol 33 910-915
[5]
Basch E(2010)The missing voice of patients in drug-safety reporting N Engl J Med 362 865-869
[6]
Basch E(2014)Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) J Natl Cancer Inst 106 dju244-1059
[7]
Iasonos A(2015)Validity and reliability of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) JAMA Oncol 1 1051-269
[8]
McDonough T(2017)Japanese translation and linguistic validation of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) J Patient Rep Outcomes 1 8-1108
[9]
Barz A(2014)Cognitive interviewing of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) Qual Life Res 23 257-2299
[10]
Culkin A(2020)Linguistic validation of the simplified Chinese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) BMC Cancer 20 1153-1088